{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T18:32:32Z","timestamp":1795199552938,"version":"4.10.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Clinical observations suggest a complex relationship between obesity and coronary artery disease (CAD). This study aimed to characterize the intermediate metabolism phenotypes among obese patients with CAD and without CAD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Sixty-two participants who consecutively underwent coronary angiography were enrolled in the discovery cohort. Transcriptional and untargeted metabolomics analyses were carried out to screen for key molecular changes between obese patients with CAD (CAD obese), without CAD (Non-CAD obese), and Non-CAD leans. A targeted GC-MS metabolomics approach was used to further identify differentially expressed metabolites in the validation cohorts. Regression and receiver operator curve analysis were performed to validate the risk model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found common aberrantly expressed pathways both at the transcriptional and metabolomics levels. These pathways included cysteine and methionine metabolism and arginine and proline metabolism. Untargeted metabolomics revealed that S-adenosylhomocysteine (SAH), 3-hydroxybenzoic acid, 2-hydroxyhippuric acid, nicotinuric acid, and 2-arachidonoyl glycerol were significantly elevated in the CAD obese group compared to the other two groups. In the validation study, targeted cysteine and methionine metabolomics analyses showed that homocysteine (Hcy), SAH, and choline were significantly increased in the CAD obese group compared with the Non-CAD obese group, while betaine, 5-methylpropanedioic acid, S-adenosylmethionine, 4-PA, and vitamin B2 (VB2) showed no significant differences. Multivariate analyses showed that Hcy was an independent predictor of obesity with CAD (hazard ratio 1.7; 95%<jats:italic>CI<\/jats:italic> 1.2\u20132.6). The area under the curve based on the Hcy metabolomic (HCY-Mtb) index was 0.819, and up to 0.877 for the HCY-Mtb.index plus clinical variables.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This is the first study to propose that obesity with hyperhomocysteinemia is a useful intermediate metabolism phenotype that could be used to identify obese patients at high risk for developing CAD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-023-01942-0","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T17:03:07Z","timestamp":1692896587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comprehensive transcriptomics and metabolomics analyses reveal that hyperhomocysteinemia is a high risk factor for coronary artery disease in a chinese obese population aged 40\u201365: a prospective cross-sectional study"],"prefix":"10.1186","volume":"22","author":[{"given":"Chong-Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-Qin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Feng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Jie","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Zhen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Feng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chao","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lie-Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"1942_CR1","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","volume":"143","author":"TM Powell-Wiley","year":"2021","unstructured":"Powell-Wiley TM, Poirier P, Burke LE, Despr\u00e9s JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: a scientific statement from the american heart association. Circulation. 2021;143:e984\u2013e1010.","journal-title":"Circulation"},{"key":"1942_CR2","first-page":"e29480","volume":"14","author":"MP Manoharan","year":"2022","unstructured":"Manoharan MP, Raja R, Jamil A, Csendes D, Gutlapalli SD, Prakash K, et al. Obesity and coronary artery disease: an updated systematic review 2022. Cureus. 2022;14:e29480.","journal-title":"Cureus"},{"key":"1942_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.metabol.2018.11.009","volume":"92","author":"C Iacobini","year":"2019","unstructured":"Iacobini C, Pugliese G, Blasetti Fantauzzi C, Federici M, Menini S. Metabolically healthy versus metabolically unhealthy obesity. Metabolism. 2019;92:51\u201360.","journal-title":"Metabolism"},{"key":"1942_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4103\/ijmr.IJMR_1768_17","volume":"151","author":"LP Mayoral","year":"2020","unstructured":"Mayoral LP, Andrade GM, Mayoral EP, Huerta TH, Canseco SP, Rodal Canales FJ, et al. Obesity subtypes, related biomarkers & heterogeneity. Indian J Med Res. 2020;151:11\u201321.","journal-title":"Indian J Med Res"},{"key":"1942_CR5","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1172\/JCI129186","volume":"129","author":"GI Smith","year":"2019","unstructured":"Smith GI, Mittendorfer B, Klein S. Metabolically healthy obesity: facts and fantasies. J Clin Investig. 2019;129:3978\u201389.","journal-title":"J Clin Investig"},{"key":"1942_CR6","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1210\/jc.2011-3475","volume":"97","author":"M Hamer","year":"2012","unstructured":"Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab. 2012;97:2482\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1942_CR7","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/ijo.2015.75","volume":"39","author":"YC Hwang","year":"2015","unstructured":"Hwang YC, Hayashi T, Fujimoto WY, Kahn SE, Leonetti DL, McNeely MJ, et al. Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype. Int J Obes (Lond). 2015;39:1365\u201370.","journal-title":"Int J Obes (Lond)"},{"key":"1942_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1161\/01.CIR.102.2.179","volume":"102","author":"I Lemieux","year":"2000","unstructured":"Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Alm\u00e9ras N, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 2000;102:179\u201384.","journal-title":"Circulation"},{"key":"1942_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nrg2934","volume":"2","author":"F Ozsolak","year":"2011","unstructured":"Ozsolak F, Milos PM. RNA sequencing: advances, challenges and opportunities. Nat Rev Genet. 2011;2:87\u201398.","journal-title":"Nat Rev Genet"},{"issue":"7","key":"1942_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","volume":"17","author":"H Caroline","year":"2016","unstructured":"Caroline H, Johnson J, Ivanisevic, Gary Siuzdak. Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol. 2016;17(7):451\u20139.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1942_CR11","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.117.311002","volume":"122","author":"RW McGarrah","year":"2018","unstructured":"McGarrah RW, Crown SB, Zhang GF, Shah SH, Newgard CB. Cardiovascular metabolomics. Circ Res. 2018;122:1238\u201358.","journal-title":"Circ Res"},{"key":"1942_CR12","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1017\/S0007114514002657","volume":"112","author":"Q Zeng","year":"2014","unstructured":"Zeng Q, He Y, Dong S, Zhao X, Chen Z, Song Z, et al. Optimal cut-off values of BMI, waist circumference and waist:height ratio for defining obesity in chinese adults. Br J Nutr. 2014;112:1735\u201344.","journal-title":"Br J Nutr"},{"key":"1942_CR13","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/ehjci\/jez070","volume":"20","author":"LE Mantella","year":"2019","unstructured":"Mantella LE, Colledanchise KN, H\u00e9tu MF, Feinstein SB, Abunassar J, Johri AM. Carotid intraplaque neovascularization predicts coronary artery disease and cardiovascular events. Eur Heart J Cardiovasc Imaging. 2019;20:1239\u201347.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1942_CR14","doi-asserted-by":"crossref","unstructured":"Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods.2015;12, 357 \u2013 60.","DOI":"10.1038\/nmeth.3317"},{"key":"1942_CR15","doi-asserted-by":"publisher","first-page":"2100284","DOI":"10.1183\/13993003.00284-2021","volume":"59","author":"H Jia","year":"2022","unstructured":"Jia H, Liu C, Li D, Huang Q, Liu D, Zhang Y, et al. Metabolomic analyses reveal new stage-specific features of COVID-19. Eur Respir J. 2022;59:2100284.","journal-title":"Eur Respir J"},{"key":"1942_CR16","doi-asserted-by":"publisher","first-page":"585","DOI":"10.14202\/vetworld.2021.585-588","volume":"14","author":"N Kunanusont","year":"2021","unstructured":"Kunanusont N, Punyadarsaniya D, Ruenphet S. Accuracy and precision guidelines for optimal breeding time in bitches using in-house progesterone measurement compared with chemiluminescent microparticle immunoassay. Vet World. 2021;14:585\u201388.","journal-title":"Vet World"},{"key":"1942_CR17","doi-asserted-by":"publisher","first-page":"13853","DOI":"10.1038\/s41598-018-32085-y","volume":"8","author":"JK Haukka","year":"2018","unstructured":"Haukka JK, Sandholm N, Forsblom C, Cobb JE, Groop PH, Ferrannini E. Metabolomic Profile Predicts Development of Microalbuminuria in individuals with type 1 diabetes. Sci Rep. 2018;8:13853.","journal-title":"Sci Rep"},{"key":"1942_CR18","doi-asserted-by":"publisher","first-page":"943185","DOI":"10.3389\/fcvm.2022.943185","volume":"9","author":"XL Lin","year":"2022","unstructured":"Lin XL, Li QY, Zhao DH, Liu JH, Fan Q. Serum glycated albumin is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents: an observational study. Front Cardiovasc Med. 2022;9:943185.","journal-title":"Front Cardiovasc Med"},{"key":"1942_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-48382-5_1","volume":"960","author":"A Engin","year":"2017","unstructured":"Engin A. The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol. 2017;960:1\u201317.","journal-title":"Adv Exp Med Biol"},{"key":"1942_CR20","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1093\/ajcn\/86.6.1581","volume":"86","author":"C Wagner","year":"2007","unstructured":"Wagner C, Koury MJ. S-Adenosylhomocysteine: a better indicator of vascular disease than homocysteine? Am J Clin Nutr. 2007;86:1581\u20135.","journal-title":"Am J Clin Nutr"},{"key":"1942_CR21","doi-asserted-by":"publisher","first-page":"918698","DOI":"10.3389\/fnut.2022.918698","volume":"9","author":"J Xiao","year":"2022","unstructured":"Xiao J, You Y, Chen X, Tang Y, Chen Y, Liu Q, et al. Higher S-adenosylhomocysteine and lower ratio of S-adenosylmethionine to S-adenosylhomocysteine were more closely associated with increased risk of subclinical atherosclerosis than homocysteine. Front Nutr. 2022;9:918698.","journal-title":"Front Nutr"},{"key":"1942_CR22","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jpba.2004.08.033","volume":"36","author":"P Pfuhl","year":"2005","unstructured":"Pfuhl P, K\u00e4rcher U, H\u00e4ring N, Baumeister A, Tawab MA, Schubert-Zsilavecz M. Simultaneous determination of niacin, niacinamide and nicotinuric acid in human plasma. J Pharm Biomed Anal. 2005;36:1045\u201352.","journal-title":"J Pharm Biomed Anal"},{"key":"1942_CR23","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.2337\/dc12-1067","volume":"36","author":"CF Huang","year":"2013","unstructured":"Huang CF, Cheng ML, Fan CM, Hong CY, Shiao MS. Nicotinuric acid: a potential marker of metabolic syndrome through a metabolomics-based approach. Diabetes Care. 2013;36:1729\u201331.","journal-title":"Diabetes Care"},{"key":"1942_CR24","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.2337\/db06-0812","volume":"55","author":"M Bl\u00fcher","year":"2006","unstructured":"Bl\u00fcher M, Engeli S, Kl\u00f6ting N, Berndt J, Fasshauer M, B\u00e1tkai S, et al. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes. 2006;55:3053\u201360.","journal-title":"Diabetes"},{"key":"1942_CR25","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.2337\/diabetes.54.10.2838","volume":"54","author":"S Engeli","year":"2005","unstructured":"Engeli S, B\u00f6hnke J, Feldpausch M, Gorzelniak K, Janke J, B\u00e1tkai S, et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes. 2005;54:2838\u201343.","journal-title":"Diabetes"},{"key":"1942_CR26","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1210\/jc.2005-2679","volume":"91","author":"I Matias","year":"2006","unstructured":"Matias I, Gonthier MP, Orlando P, Martiadis V, De Petrocellis L, Cervino C, et al. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J Clin Endocrinol Metab. 2006;91:3171\u201380.","journal-title":"J Clin Endocrinol Metab"},{"key":"1942_CR27","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1038\/s41401-020-00589-x","volume":"42","author":"CK Cheng","year":"2021","unstructured":"Cheng CK, Luo JY, Lau CW, Cho WC, Ng CF, Ma RCW, et al. A GLP-1 analog lowers ER stress and enhances protein folding to ameliorate homocysteine-induced endothelial dysfunction. Acta Pharmacol Sin. 2021;42:1598\u2013609.","journal-title":"Acta Pharmacol Sin"},{"key":"1942_CR28","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2143\/AC.60.6.2004935","volume":"60","author":"S Yologlu","year":"2005","unstructured":"Yologlu S, Sezgin AT, Sezgin N, Ozdemir R, Yesilada E, Topal E. Determination of risk factors in obese and non-obese patients with coronary artery disease. Acta Cardiol. 2005;60:625\u20139.","journal-title":"Acta Cardiol"},{"key":"1942_CR29","first-page":"322","volume":"40","author":"S Kouzehgaran","year":"2015","unstructured":"Kouzehgaran S, Vakili R, Nematy M, Safarian M, Ghayour-Mobarhan M, Khajedaluee M. Comparison of novel coronary artery disease risk factors between obese and normal adolescent. Iran J Med Sci. 2015;40:322\u20137.","journal-title":"Iran J Med Sci"},{"key":"1942_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.dsx.2016.08.026","volume":"11","author":"B Sreckovic","year":"2017","unstructured":"Sreckovic B, Sreckovic VD, Soldatovic I, Colak E, Sumarac-Dumanovic M, Janeski H, et al. Homocysteine is a marker for metabolic syndrome and atherosclerosis. Diabetes Metab Syndr. 2017;11:179\u201382.","journal-title":"Diabetes Metab Syndr"},{"key":"1942_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0955-2863(01)00197-8","volume":"13","author":"V Sanchez-Margalet","year":"2002","unstructured":"Sanchez-Margalet V, Valle M, Ruz FJ, Gascon F, Mateo J, Goberna R. Elevated plasma total homocysteine levels in hyperinsulinemic obese subjects. J Nutr Biochem. 2002;13:75\u20139.","journal-title":"J Nutr Biochem"},{"key":"1942_CR32","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.4065\/83.11.1203","volume":"83","author":"LL Humphrey","year":"2008","unstructured":"Humphrey LL, Fu R, Rogers K, Freeman M, Helfand M. Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin Proc. 2008;83:1203\u201312.","journal-title":"Mayo Clin Proc"},{"key":"1942_CR33","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/BF03345325","volume":"28","author":"O Uysal","year":"2005","unstructured":"Uysal O, Arikan E, Cakir B. Plasma total homocysteine level and its association with carotid intima-media thickness in obesity. J Endocrinol Invest. 2005;28:928\u201334.","journal-title":"J Endocrinol Invest"},{"key":"1942_CR34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/14779072.2018.1497974","volume":"16","author":"SG Chrysant","year":"2018","unstructured":"Chrysant SG, Chrysant GS. The current status of homocysteine as a risk factor for cardiovascular disease: a mini review. Expert Rev Cardiovasc Ther. 2018;16:559\u201365.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"1942_CR35","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/jn\/nxab367","volume":"152","author":"A Van Parys","year":"2022","unstructured":"Van Parys A, Br\u00e6kke MS, Karlsson T, Vinknes KJ, Tell GS, Haugsgjerd TR, et al. Assessment of dietary choline intake, contributing food items, and associations with one-carbon and lipid metabolites in middle-aged and elderly adults: the hordaland health study. J Nutr. 2022;152:513\u201324.","journal-title":"J Nutr"},{"key":"1942_CR36","doi-asserted-by":"publisher","first-page":"6516","DOI":"10.1080\/10408398.2021.1902938","volume":"62","author":"D Ashtary-Larky","year":"2022","unstructured":"Ashtary-Larky D, Bagheri R, Ghanavati M, Asbaghi O, Tinsley GM, Mombaini D, et al. Effects of betaine supplementation on cardiovascular markers: a systematic review and Meta-analysis. Crit Rev Food Sci Nutr. 2022;62:6516\u201333.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1942_CR37","unstructured":"Angelini A, Cappuccilli ML, Magnoni G, Croci Chiocchini AL, Aiello V, Napoletano A et al. The link between homocysteine, folic acid and vitamin B12 in chronic kidney disease. G Ital Nefrol. 2021;38."},{"key":"1942_CR38","first-page":"Cd006612","volume":"1","author":"AJ Mart\u00ed-Carvajal","year":"2015","unstructured":"Mart\u00ed-Carvajal AJ, Sol\u00e0 I, Lathyris D. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2015;1:Cd006612.","journal-title":"Cochrane Database Syst Rev"},{"key":"1942_CR39","first-page":"4598","volume":"8","author":"J Li","year":"2016","unstructured":"Li J, Luo M, Xie N, Wang J, Chen L. Curcumin protects endothelial cells against homocysteine induced injury through inhibiting inflammation. Am J Transl Res. 2016;8:4598\u2013604.","journal-title":"Am J Transl Res"},{"key":"1942_CR40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/jcmm.16073","volume":"25","author":"J Chen","year":"2021","unstructured":"Chen J, Huang Y, Hu X, Bian X, Nian S. Gastrodin prevents homocysteine-induced human umbilical vein endothelial cells injury via PI3K\/Akt\/eNOS and Nrf2\/ARE pathway. J Cell Mol Med. 2021;25:345\u201357.","journal-title":"J Cell Mol Med"},{"key":"1942_CR41","doi-asserted-by":"publisher","first-page":"e1001177","DOI":"10.1371\/journal.pmed.1001177","volume":"9","author":"R Clarke","year":"2012","unstructured":"Clarke R, Bennett DA, Parish S, Verhoef P, D\u00f6tsch-Klerk M, Lathrop M, et al. Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. PLoS Med. 2012;9:e1001177.","journal-title":"PLoS Med"},{"key":"1942_CR42","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1515\/CCLM.2011.062","volume":"49","author":"D Haj Mouhamed","year":"2011","unstructured":"Haj Mouhamed D, Ezzaher A, Neffati F, Douki W, Najjar MF. Effect of cigarette smoking on plasma homocysteine concentrations. Clin Chem Lab Med. 2011;49:479\u201383.","journal-title":"Clin Chem Lab Med"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01942-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-01942-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01942-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T16:20:34Z","timestamp":1700324434000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-01942-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1942"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-01942-0","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"assertion":[{"value":"15 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the guidelines stipulated in the Declaration of Helsinki and approved by the research ethics committee of the Second Affiliated Hospital of Guangzhou Medical University. Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"219"}}